- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02142686
Comparison Between Different Filling Pressures in Diagnostic Outpatient Hysteroscopy
Comparison Between Different Filling Pressures in Diagnostic Outpatient Hysteroscopy: A Double Blinded Randomised Controlled Trial.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
This study is a prospective double blinded randomised controlled trial. 240 women will be randomly divided into 3 groups, each containing 70 women. Randomisation will be performed using a computer generated random numbers and sealed envelopes.
Full history will be taken followed by general and local examination. The procedure will be done in the lithotomy position. Hysteroscopy will be done using a 5mm outer diameter continuous flow hysteroscope with a French working channel and a 30 degrees direction of view provided by Techno GmbH and CO. The hysteroscope will be introduced using the vaginoscopy technique, in which no speculum will be used. The cervix will be detected and the external os will be identified using the hysteroscope. The hysteroscope will be introduced in the uterine cavity. Saline will be used as the distension medium and the pressure will be set at 80mm Hg until the hysteroscope is introduced in the uterine cavity. After the hysteroscope is introduced into the uterine cavity, the filling pressure will remain at 80mm Hg in group1, will be reduced to 50mm Hg in group 2 and to 30mmHg in group 3. Randomisation will be double blind; neither the operator nor the patient will know the pressure during the procedure, a third party will set the pressure according to the computer generated random numbers.
The anterior wall, posterior wall and tubal ostea will be visualised, any polyps, adhesions septa, congenital malformations or submucous fibroids will be noted.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Cairo, Egypt
- Cairo University Hospitals
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Age 18-60 years
- Has a clear Indication to have an outpatient hysteroscopy
- Consent to participate in the study
Exclusion Criteria:
- Premenstrual and midmenstrual patients.
- Patients with missed periods.
- Patients with known cardiac disease.
- Patients who need operative hysteroscopy
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Quadruple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: Filling pressure 80
After the hysteroscope is introduced into the uterine cavity, the filling pressure will remain at 80mm.
|
After the hysteroscope is introduced into the uterine cavity, the filling pressure will remain at 80mm Hg.
|
Active Comparator: Filling pressure 50.
After the hysteroscope is introduced into the uterine cavity, the filling pressure will be reduced to 50mm Hg in this group
|
After the hysteroscope is introduced into the uterine cavity, the filling pressure will be reduced to 50mm Hg.
|
Active Comparator: illing pressure 30
After the hysteroscope is introduced into the uterine cavity, the filling pressure will be reduced to 30mm Hg.
|
After the hysteroscope is introduced into the uterine cavity, the filling pressure will be reduced to 30mm
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
adequate visualization of the uterine cavity
Time Frame: 10 minutes after starting the procedure.
|
10 minutes after starting the procedure, the operator will document if adequate visualization was achieved using the allocated pressure.
If visualization was not adequate, he will document that adequate visualization was not achieved using the allocated pressure and will ask for the pressure to be adjusted.
|
10 minutes after starting the procedure.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Pain perceived by the patient
Time Frame: 10 minutes after starting the procedure
|
Pain will be assessed by a visual analogue scale 10 minutes after starting the procedure.
|
10 minutes after starting the procedure
|
Pain perceived by the patient 30 minutes after starting the procedure.
Time Frame: 30 minutes after starting the procedure.
|
Pain will be assessed by a visual analogue scale 30 minutes after starting the procedure.
|
30 minutes after starting the procedure.
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: AbdelGany M A Hassan, MRCOG, MD, Cairo University
Publications and helpful links
General Publications
- van Dongen H, de Kroon CD, Jacobi CE, Trimbos JB, Jansen FW. Diagnostic hysteroscopy in abnormal uterine bleeding: a systematic review and meta-analysis. BJOG. 2007 Jun;114(6):664-75. doi: 10.1111/j.1471-0528.2007.01326.x.
- Sharma JB, Aruna J, Kumar P, Roy KK, Malhotra N, Kumar S. Comparison of efficacy of oral drotaverine plus mefenamic acid with paracervical block and with intravenous sedation for pain relief during hysteroscopy and endometrial biopsy. Indian J Med Sci. 2009 Jun;63(6):244-52.
- O'Flynn H, Murphy LL, Ahmad G, Watson AJ. Pain relief in outpatient hysteroscopy: a survey of current UK clinical practice. Eur J Obstet Gynecol Reprod Biol. 2011 Jan;154(1):9-15. doi: 10.1016/j.ejogrb.2010.08.015.
- Shahid A, Pathak M, Gulumser C, Parker S, Palmer E, Saridogan E. Optimum uterine filling pressure for outpatient diagnostic hysteroscopy: a double-blind, randomized controlled trial. Reprod Biomed Online. 2014 Jan;28(1):86-91. doi: 10.1016/j.rbmo.2013.07.018. Epub 2013 Sep 14.
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- Hyst 1
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Hysteroscopy
-
Wenzhou Medical UniversityCompleted
-
EgymedicalpediaCompleted
-
Cairo UniversityCompleted
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityNot yet recruitingHysteroscopy | Ciprofol
-
Fundació Institut de Recerca de l'Hospital de la...CompletedHysteroscopy | OutpatientSpain
-
Cairo UniversityCompletedOffice HysteroscopyEgypt
-
Birmingham Women's NHS Foundation TrustCompletedHysteroscopy TechniqueUnited Kingdom
-
University of Campinas, BrazilUnknownHysteroscopy | Postmenopausal WomenBrazil
-
Assuta Ashdod HospitalCompletedAnesthesia, Local | Office HysteroscopyIsrael
Clinical Trials on Filling pressure 80
-
Cairo UniversityCompleted
-
Catharina Ziekenhuis EindhovenCompletedShock, Cardiogenic | Hypovolemia | Cardiac Failure | Shock HypovolemicNetherlands
-
Koç UniversityRecruitingMultiple Sclerosis | Neurogenic BladderTurkey
-
St George's, University of LondonCompleted
-
Seyda Ersahan, DDS, PhDActive, not recruitingApical Periodontitis | Periapical LesionTurkey
-
Weill Medical College of Cornell UniversityNational Heart, Lung, and Blood Institute (NHLBI)CompletedCoronary Artery Bypass Graft Surgery PatientsUnited States
-
University Hospital, AngersRecruiting
-
University Hospital, AngersNot yet recruiting
-
Centre Hospitalier Universitaire de NīmesUnknownCritical Illness | Covid19 | Stress Disorders, Post-TraumaticFrance
-
Women's College HospitalTerminatedPostoperative Complications | Surgery | Urinary RetentionCanada